Combined protective effects of anti-PhtD and anti-pneumococcal polysaccharides

被引：13
|
作者：
Denoel, Philippe [1 ]
Godfroid, Fabrice [1 ]
Hermand, Philippe [1 ]
Verlant, Vincent [1 ]
Poolman, Jan [1 ]
机构：
[1] GlaxoSmithKline Biol, Res & Dev, B-1330 Rixensart, Belgium
来源：
VACCINE | 2011年 / 29卷 / 38期
关键词：
Antibody; PhtD; Streptococcus pneumoniae; Serotype; 1; 3; ACUTE OTITIS-MEDIA; CONJUGATE VACCINE; DOUBLE-BLIND; PROTEIN-D; EFFICACY; CHILDREN; EMPYEMA; TRIAL; IMMUNOGENICITY; PNEUMONIA;
D O I：
10.1016/j.vaccine.2011.01.085
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
In the past years, a significant rise in the proportion of childhood complicated pneumonia cases related to pneumococcal serotypes 1 and 3 has been observed. PhtD is a vaccine candidate protein antigen. By using a pneumococcal lethal intranasal challenge mouse model, a significant additive effect on protection was observed with the combination of vaccination-induced anti-PhtD and injected anti-polysaccharide antibodies specific for serotypes 1 and 3. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码：6451 / 6453
页数：3
相关论文
共 50 条
  • [41] Rapid decline of anti-pneumococcal antibody levels in nephrotic children
    Ayfer Gür Güven
    Sema Akman
    Elif Bahat
    Mustafa Senyurt
    Selma Yüzbey
    Aysen Uguz
    Olcay Yegin
    [J]. Pediatric Nephrology, 2004, 19 : 61 - 65
  • [42] Anti-pneumococcal vaccines in sickle-cell anemia and asplenism
    Cohen, R
    [J]. PRESSE MEDICALE, 2003, 32 (28): : S12 - S14
  • [43] COST-EFFECTIVENESS ANALYSIS OF ANTI-PNEUMOCOCCAL VACCINES IN GUATEMALA
    Lutz, M. A.
    Grazioso, C.
    Morales, G.
    Strutton, D. R.
    Roberts, C. S.
    Farkouh, R. A.
    Cuesta, G.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A277 - A277
  • [44] COST-EFFECTIVENESS ANALYSIS OF ANTI-PNEUMOCOCCAL VACCINES IN PANAMA
    Lutz, M. A.
    Luciani, K.
    Morales, G.
    Strutton, D. R.
    Roberts, C. S.
    Farkouh, R. A.
    Cuesta, G.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A276 - A277
  • [45] A QUANTITATIVE-ANALYSIS OF THE INTERACTIONS OF ANTI-PNEUMOCOCCAL ANTIBODY AND COMPLEMENT IN EXPERIMENTAL PNEUMOCOCCAL BACTEREMIA
    BROWN, EJ
    HOSEA, SW
    HAMMER, CH
    BURCH, CG
    FRANK, MM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1982, 69 (01): : 85 - 98
  • [46] CLASS AND SUBCLASS ANTI-PNEUMOCOCCAL ANTIBODY-RESPONSES IN SPLENECTOMIZED PATIENTS
    OLDFIELD, S
    JENKINS, S
    YEOMAN, H
    GRAY, D
    MACLENNAN, ICM
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1985, 61 (03): : 664 - 673
  • [47] Anti-pneumococcal antibody response in normal subjects: A meta-analysis
    Go, ES
    Ballas, ZK
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (01) : 205 - 215
  • [48] PRIMARY MURINE IMMUNOGLOBULIN-M RESPONSES TO CERTAIN PNEUMOCOCCAL CAPSULAR POLYSACCHARIDES CONSIST PRIMARILY OF ANTI-PNEUMOCOCCAL CELL-WALL CARBOHYDRATE ANTIBODIES
    FAIRCHILD, RL
    STERNER, KE
    BRALEYMULLEN, H
    [J]. INFECTION AND IMMUNITY, 1986, 52 (03) : 867 - 871
  • [49] RAISED IGA ANTI-PNEUMOCOCCAL ANTIBODIES IN IGA NEPHROPATHY (IGA GN)
    DREW, PA
    NIEUWHOF, WN
    CLARKSON, AR
    WOODROFFE, AJ
    [J]. KIDNEY INTERNATIONAL, 1986, 30 (04) : 629 - 629
  • [50] Specific production of anti-pneumococcal antibodies in patients with Fanconi anaemia.
    Roxo, P
    Ferriani, VPL
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : S143 - S143
12345